Its convenient and perfect for busy professionals and students
Stuart MC, Kouimtzi M, Hill SR (eds.)
AOD-9604 Safety: What Do Clinical Trials Show
How They Work Support hepatic fat metabolism via MIC compounds Deliver nutrients at 100% IM absorption Support liver function and fat export Inositol sensitizes insulin signaling B12 restores metabolic energy foundation Best results as part of a broader protocol What Patients Report Improved energy levels often from week 1 Reduced afternoon fatigue Improved exercise capacity and recovery Reduced carbohydrate cravings (inositol) More consistent weight management progress Results vary with diet, exercise, and baseline How They Differ GLP-1: appetite suppression + glucose regulation Lipotropic: fat metabolism + liver function Not competitive different mechanisms Commonly combined for complementary support B12 addresses fatigue GLP-1 patients experience Inform your NP of all current medications Benefits of B12 & Lipotropic Injections
Currently, the phase 3 trial is expected to continue through the end of 2025 (4), and afterwards the drug application would be submitted to the Food and Drug Administration (FDA) for approval
Combining NAD+ and AOD9604 may offer synergistic benefits, addressing both cellular health and metabolic efficiency, though this approach requires further robust scientific investigation
